Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
MUPRO IFT.
836422
5
DANAU
831855
US Stock MarketDetailed Quotes
SUPN Supernus Pharmaceuticals
- 32.270
- -0.470-1.44%
Close Apr 7 16:00 ET
- 32.270
- 0.0000.00%
Post 17:04 ET
1.80BMarket Cap24.45P/E (TTM)
34.260High31.970Low1.21MVolume32.150Open32.740Pre Close39.61MTurnover2.50%Turnover Ratio24.45P/E (Static)55.81MShares40.28052wk High1.74P/B1.56BFloat Cap25.53052wk Low--Dividend TTM48.49MShs Float61.250Historical High--Div YieldTTM7.00%Amplitude4.300Historical Low32.629Avg Price1Lot Size
Supernus Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 54.79%171.95M | -1.23%44.41M | 49.18%53.52M | 288.75%35.62M | -21.83%38.4M | -4.91%111.09M | 63.10%44.96M | 159.19%35.88M | -126.54%-18.87M | 1,041.93%49.13M |
| Net income from continuing operations | 5,512.84%73.87M | 1,204.51%15.33M | 340.97%38.5M | 2,496.63%19.92M | -99.27%124K | -97.83%1.32M | -95.39%1.18M | -1,013.44%-15.98M | -110.57%-831K | -33.84%16.95M |
| Operating gains losses | ---9K | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -5.24%80.41M | -13.06%18.85M | -8.03%20.1M | -0.03%20.72M | 0.72%20.75M | -0.80%84.86M | 3.97%21.68M | 0.38%21.86M | -3.86%20.73M | -3.56%20.6M |
| Deferred tax | 21.69%-20.14M | 99.31%-72K | 30.21%-6.47M | -46.11%-8.12M | -1,160.23%-5.48M | 2.32%-25.71M | -34.78%-10.46M | -269.61%-9.27M | -82.34%-5.55M | 96.66%-435K |
| Other non cash items | -71.19%1.42M | 91.65%-400K | -59.93%642K | -102.68%-181K | 0.74%1.35M | 140.30%4.91M | 55.47%-4.79M | -84.27%1.6M | 675,900.00%6.76M | 111.57%1.34M |
| Change In working capital | 77.54%-2.05M | -359.83%-5.13M | -126.58%-7.89M | 93.72%-2.9M | 155.91%13.87M | 58.74%-9.14M | 113.19%1.97M | 221.14%29.67M | -218.36%-46.2M | 124.95%5.42M |
| -Change in receivables | -88.93%2.08M | 239.37%3.33M | 236.03%7.09M | -208.35%-4.76M | -116.29%-3.58M | 214.66%18.77M | -69.74%-2.39M | 11.18%-5.21M | 134.04%4.39M | 476.36%21.97M |
| -Change in inventory | 158.69%15.81M | -36.61%3.19M | -33.39%4.6M | 251.42%6.03M | 207.51%1.99M | 134.21%6.11M | 143.52%5.03M | 184.85%6.91M | -192.32%-3.98M | 25.00%-1.85M |
| -Change in prepaid assets | -5,694.01%-19.35M | -238.52%-10.81M | -108.59%-1.75M | 102.58%728K | -2,104.40%-7.52M | -102.71%-334K | -15.22%7.8M | 1,556.33%20.41M | -3,603.48%-28.2M | -132.14%-341K |
| -Change in payables and accrued expense | 98.27%-584K | 90.12%-837K | -335.71%-17.82M | 73.41%-4.9M | 259.95%22.97M | -15,070.27%-33.68M | 36.37%-8.47M | 164.55%7.56M | -139.32%-18.41M | 34.79%-14.36M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 54.79%171.95M | -1.23%44.41M | 49.18%53.52M | 288.75%35.62M | -21.83%38.4M | -4.91%111.09M | 63.10%44.96M | 159.19%35.88M | -126.54%-18.87M | 1,041.93%49.13M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -170.65%-189.87M | 80.85%-12.64M | -322.36%-77.01M | -180.59%-48.59M | -121.53%-51.62M | 224.03%268.73M | -35.30%-65.98M | 142.12%34.63M | 484.57%60.3M | 442.61%239.78M |
| Net PPE purchase and sale | -31.58%-725K | -691.67%-213K | -33.33%-200K | 59.75%-64K | 10.79%-248K | -33.74%-551K | 260.00%36K | -2.04%-150K | -127.60%-159K | 67.33%-278K |
| Net investment purchase and sale | -170.24%-189.14M | 81.18%-12.43M | -320.82%-76.81M | -180.27%-48.53M | -121.40%-51.38M | 224.52%269.28M | -35.35%-66.02M | 142.38%34.78M | 471.92%60.46M | 447.23%240.06M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -170.65%-189.87M | 80.85%-12.64M | -322.36%-77.01M | -180.59%-48.59M | -121.53%-51.62M | 224.03%268.73M | -35.30%-65.98M | 142.12%34.63M | 484.57%60.3M | 442.61%239.78M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 103.06%12.19M | 439.38%5.89M | 1,436.96%3.08M | 100.35%1.66M | -98.04%1.57M | -3,697.65%-397.88M | -61.40%1.09M | -103.56%-230K | -21,169.78%-478.92M | 463.86%80.17M |
| Net issuance payments of debt | --0 | --0 | --0 | --0 | --0 | ---402.5M | --0 | --0 | ---480.86M | --78.36M |
| Net common stock issuance | 125.54%14.91M | 529.76%6.88M | 367.84%3.46M | -34.22%1.66M | 28.99%2.91M | -46.79%6.61M | -61.40%1.09M | -88.54%740K | 10.95%2.52M | 160.51%2.26M |
| Net other financing activities | -36.43%-2.72M | ---987K | 60.10%-387K | 99.83%-1K | -201.12%-1.34M | 91.31%-1.99M | --0 | ---970K | ---575K | 98.06%-445K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 103.06%12.19M | 439.38%5.89M | 1,436.96%3.08M | 100.35%1.66M | -98.04%1.57M | -3,697.65%-397.88M | -61.40%1.09M | -103.56%-230K | -21,169.78%-478.92M | 463.86%80.17M |
| Net cash flow | ||||||||||
| Beginning cash position | -19.40%75.05M | -66.65%31.67M | 110.84%52.09M | -86.28%63.4M | -19.40%75.05M | -54.23%93.12M | -14.81%94.99M | -85.75%24.71M | 299.43%462.2M | -54.23%93.12M |
| Current changes in cash | 68.32%-5.72M | 288.94%37.66M | -129.05%-20.42M | 97.41%-11.31M | -103.16%-11.65M | 83.62%-18.07M | -8.49%-19.93M | 213.47%70.28M | -858.05%-437.49M | 520.75%369.08M |
| End cash Position | -7.63%69.33M | -7.63%69.33M | -66.65%31.67M | 110.84%52.09M | -86.28%63.4M | -19.40%75.05M | -19.40%75.05M | -14.81%94.99M | -85.75%24.71M | 299.43%462.2M |
| Free cash flow | 54.91%171.23M | -1.78%44.19M | 49.25%53.32M | 286.83%35.56M | -21.89%38.15M | -5.05%110.53M | 63.18%44.99M | 160.88%35.73M | -126.55%-19.03M | 1,315.47%48.85M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call